Novogene specializes in the application of advanced molecular biotechnology and high-performance computing in the research fields of life science and human health. Established in March 2011, Novogene strives to become a global leader in providing genetic science services and technology products. Novogene has set up operations and laboratories in the United States, the United Kingdom, Netherlands, Germany, as well as in China, Singapore and Japan. Our partners are worldwide and include more than 4,200 scientific research institutions and universities, more than 680 hospitals and over 2,400 pharmaceutical and agricultural enterprises. Currently, Novogene has obtained 356 software copyrights and 66 patents.
Advantages with Novogene:
- One of the largest global sequencing capacities
- State-of-the-art technologies
- Highest quality data and fast turn-around time
- Rich experiences with bioinformatics support and publication-ready data
- High-educated teams support every step of the services